Viewing Study NCT03116594


Ignite Creation Date: 2025-12-25 @ 1:45 AM
Ignite Modification Date: 2026-04-22 @ 2:00 PM
Study NCT ID: NCT03116594
Status: COMPLETED
Last Update Posted: 2017-04-17
First Post: 2017-04-12
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Immunogenicity and Safety of Two Lots of NBP608 Compared to Zostavax in Healthy Adult Aged 50 and Over
Sponsor: SK Chemicals Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module